PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-06-01

Date Title Company
01-Jun-2022 Transcat Strengthens Central Region Presence with Acquisition of Alliance Calibration Businesswire
01-Jun-2022 Rallybio to Present at Upcoming Investor Conferences in June Businesswire
01-Jun-2022 Moxe Health Raises $30M Series B to Further Advance Interoperability Businesswire
01-Jun-2022 Agilent Releases IVDR-Compliant Instruments, Kits, and Reagents for Use in the European Union Businesswire
01-Jun-2022 Stoke Therapeutics to Present at the 2022 Jefferies Healthcare Conference Businesswire
01-Jun-2022 Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share Dermapharm Holding SE
01-Jun-2022 Artificial Intelligence in Drug Discovery Market Research Report 2022 - ResearchAndMarkets.com Businesswire
01-Jun-2022 ADC Therapeutics to Present at the Jefferies Healthcare Conference Businesswire
01-Jun-2022 武田在ASCO和EHA上展示腫瘤學產品組合和研發產品線的最新研究成果 Businesswire
01-Jun-2022 武田在ASCO和EHA上展示肿瘤学产品组合和研发产品线的最新研究成果 Businesswire
01-Jun-2022 Virios Therapeutics’ Study Featured in Peer-Reviewed Journal Publication Highlighting Association of Herpes Simplex Type 1 Viral Infection with Common Gastrointestinal Disorders, Including in Patients with Comorbid Fibromyalgia Businesswire
01-Jun-2022 BELLUS Health to Participate in the Jefferies Healthcare Conference Businesswire
01-Jun-2022 Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference Businesswire
01-Jun-2022 Late-Breaking Data at EULAR 2022 Demonstrate Deucravacitinib Significantly Improved Disease Activity in Phase 2 PAISLEY Study in Systemic Lupus Erythematosus Businesswire
01-Jun-2022 KalVista Pharmaceuticals to Present at 13th Annual Jefferies Healthcare Conference Businesswire
01-Jun-2022 Almac Discovery nominates a first candidate molecule from its Protein Drug Conjugate (PDC) Platform to progress into pre-clinical development Almac Discovery
01-Jun-2022 Amolyt Pharma Announces Positive Results from First Patient Cohort of Phase 2a Trial of AZP-3601 for the Treatment of Hypoparathyroidism Amolyt Pharma
01-Jun-2022 Vetter Publishes First Sustainability Report B3C newswire
01-Jun-2022 ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates ProQR Therapeutics N.V.
01-Jun-2022 HUTCHMED Announces TAZVERIK® Approved to be Used in Hainan Pilot Zone in China HUTCHMED